Quoin Pharmaceuticals (QNRX) Scheduled to Post Earnings on Thursday

Quoin Pharmaceuticals (NASDAQ:QNRX) is scheduled to be releasing its earnings data before the market opens on Thursday, November 7th. Analysts expect Quoin Pharmaceuticals to post earnings of ($0.44) per share for the quarter.

Quoin Pharmaceuticals (NASDAQ:QNRX) last released its earnings results on Thursday, August 8th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.75) by $0.36. During the same period in the previous year, the firm posted ($2.13) EPS. On average, analysts expect Quoin Pharmaceuticals to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quoin Pharmaceuticals Price Performance

NASDAQ:QNRX opened at $0.75 on Wednesday. Quoin Pharmaceuticals has a fifty-two week low of $0.48 and a fifty-two week high of $6.18. The stock’s 50-day moving average is $0.65 and its two-hundred day moving average is $0.65. The stock has a market cap of $2.99 million, a PE ratio of -0.14 and a beta of 1.85.

Quoin Pharmaceuticals Company Profile

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.